On November 16, “the Best Listed Companies in Greater China in 2020” award ceremony hosted by Gelonghui was grandly held in Chengdu. Through screening layer by layer, Joincare Pharmaceutical Group Industry Co., Ltd. won “Outstanding Contribution Award of Anti-epidemic” from many candidate enterprises.

Gelonghui, the sponsor of this event, is a leading global investment research platform in China. It firstly proposed the investment concept of “Global vision, bet on China”, integrated financial media, financial public relations, research, investment bank, data base and other roles in one, and provide one-stop services of data, market, information, research, transaction, social contact for Chinese investors’ foreign investment as well as Chinese companies’ foreign financing. According to the sponsor, the selection covers all Chinese listed companies listed on Hong Kong Stock Exchange, Shanghai Stock Exchange, Shenzhen Stock Exchange and the U.S. stock market, invited authoritative representatives from universities, securities companies and institutions to form an expert panel and selected the best listed company of the year from value, growth, innovation, social responsibility, brand influence and other aspects.

 “Outstanding Contribution Award of Anti-epidemic”, the highlight of this selection, is the final result of comprehensive evaluation based on the initiative of enterprises and their actively responses to the call of the state in fighting the COVID-19 epidemic through the way of “Expert panel review + Big data analysis”. It is aims to commend the listed companies that have made outstanding contributions to the fight against the epidemic in the capital markets.

Under the leadership of Chairman Zhu Baoguo, Joincare has participated in public benefit activities for a long time. Since the outbreak of COVID-19 this year, the Group has always been on the frontline of fighting the epidemic. In this regard, the jury said that Joincare’s corporate responsibility in the face of the epidemic situation was the key factor for wining this award. 

<1. In order to fight COVID-19 epidemic, Joincare and its holding company Livzon Pharmaceutical Group Co., Ltd. donated 22 million yuan in January, including 10 million in cash and 12 million yuan of medical supplies.

2. Joincare donated 3,230 boxes of American ginseng tea and 1,000 boxes of probiotic products to medical workers of Third People’s Hospital of Shenzhen with a total amount of 1 million yuan, supporting the prevention and control war of the only designated treatment hospital of Shenzhen in the epidemic.

3. During the period of fighting epidemic, Joincare didn’t forget targeted poverty alleviation, and donated Meropenem for injection to Xianghai Natural Reserve of Tongyu County, Baicheng City, Jilin Province, relieving the shortage of medical supplies during the epidemic prevention and control of that poverty-stricken area.>

Over the years, Joincare has actively been involved in all kinds of charities, donating more than 100 million yuan to environmental protection, education and medical services, poverty relief and disaster relief, etc. From fighting SARS to Wenchuan Earthquake and Typhoon Hato, whenever there was a major natural disaster in our country, the Group would actively give a helping hand. This time, during the period of fighting epidemic in our country, the Group continued the fine tradition of the past, and continued to output positive energy to the society with a high sense of social responsibility and patriotism.